Swiss Strategy Launches “BUZZ” – The World’s First Caffeinated Natural Alpine Swiss Cheese

Zürich, Switzerland – Swiss Strategy Aktiengesellschaft (A.G.) is thrilled to announce the launch of “BUZZ,” the world’s first caffeinated natural Alpine Swiss cheese.

For those struggling with sleepiness on their hike to the Matterhorn due to altitude sickness, "BUZZ" Caffeinated Natural Alpine Swiss Cheese might be the ideal solution. This innovative cheese combines the rich tradition of Swiss cheese-making with the energizing effects of caffeine, resulting in an extended-release supplement.

Research has shown that caffeine is fully absorbed by the gastrointestinal tract within an hour, with peak plasma concentrations occurring between 15 and 120 minutes following ingestion. Studies on time-release caffeine supplements have demonstrated enhanced alertness and improved reaction performance for up to 13 hours after ingestion.

While "BUZZ" Caffeinated Natural Alpine Swiss Cheese can provide a boost in energy, it is not recommended for extreme activities such as climbing Mount Everest without supplemental oxygen. Supplemental oxygen helps climbers stay warm, move faster, and reduce fatigue. It also helps prevent or mitigate severe hypoxia, which can occur at extreme altitudes.

At the summit of Mount Everest, which stands at 29,032 feet (8,849 meters) above sea level, there's only about 33% of the oxygen available at sea level. This "death zone" challenges climbers significantly, even with supplemental oxygen, making it feel like "running on a treadmill and breathing through a straw."

Swiss Strategy A.G. is currently in discussions with private and institutional investors, as well as potential licensees in Europe and overseas, to finance the global market launch of “BUZZ” Caffeinated Natural Alpine Swiss Cheese.

About Swiss Strategy Aktiengesellschaft:

Swiss Strategy Aktiengesellschaft is a Swiss marketing firm dedicated to promoting science-based innovations for the benefit of the economy and society in Switzerland. The company facilitates partnerships between motivated scientists and the Swiss marketplace, supporting the development of inspiring patented inventions, successful start-ups, and innovative products and services.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.*

For further information and media inquiries, please contact:

Marina Krueger, Ph.D.  

Chief Medical Officer  

Swiss Strategy Aktiengesellschaft  

Phone: +41 79 123 57 84  

Email: beveragetelevision@gmail.com 

Website: Swiss Strategy http://tinyurl.com/Swiss-Strategy

SOURCE: Swiss Strategy A.G.